🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Status
Unknown
Location
Beijing Ditan hospital,Capital Medical University
Start Date
2016-01
Trial ID
NCT03210506
Treatments Being Tested
Hepatitis B virus (HBV) infection is prevalent across the world. Functional...
Status
Unknown
Location
Qilu hospital of Shandong University
Start Date
2024-01-06
Trial ID
NCT06196632
Treatments Being Tested
The primary purpose of this research study is to test the safety and possib...
Status
Withdrawn
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-07
Trial ID
NCT05729139
Treatments Being Tested
This protocol is an open label, single arm, non-randomized, phase I / II cl...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2015-01
Trial ID
NCT02328755
Treatments Being Tested
The cohort of post-menopausal women represents a group of very-difficult-to...
Status
Unknown
Location
Gastroenterology Unit
Start Date
2011-11
Trial ID
NCT01457937
Treatments Being Tested
Our previous collaborative studies has developed a molecular diagnosis tool...
Status
Completed
Location
Kaohsiung Medical University Hospital
Start Date
2006-08
Trial ID
NCT00680173
Treatments Being Tested
This study proposes to compare the effect of 48 weeks exposure to pegylated...
Status
Unknown
Location
Pusan National University Hospital
Start Date
2013-05
Trial ID
NCT01769833
Treatments Being Tested
The objective of the study is to evaluate the safety and efficacy of celgos...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00217139
Treatments Being Tested
RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2002-07
Trial ID
NCT00085384
Treatments Being Tested
Pegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Status
Unknown
Location
Beijing Ditan hospital,Capital Medical University
Start Date
2016-01
Trial ID
NCT03209037
Treatments Being Tested